PURNIMA TEEGAVARAPU

Concepts (36)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
4
2017
454
0.860
Why?
Sarcoma, Ewing
1
2017
117
0.470
Why?
Neuroendocrine Tumors
1
2014
70
0.390
Why?
Safety-net Providers
1
2025
89
0.210
Why?
Cystitis
1
2005
48
0.210
Why?
Sulfonamides
2
2016
297
0.200
Why?
Eosinophilia
1
2005
109
0.200
Why?
Carcinoma, Renal Cell
2
2016
246
0.200
Why?
Pyrimidines
2
2016
452
0.190
Why?
Hodgkin Disease
1
2025
312
0.190
Why?
Receptors, Vascular Endothelial Growth Factor
1
2015
56
0.120
Why?
Antineoplastic Agents
2
2016
1811
0.110
Why?
Angiogenesis Inhibitors
1
2015
113
0.110
Why?
TOR Serine-Threonine Kinases
1
2015
427
0.100
Why?
Retrospective Studies
5
2025
17763
0.100
Why?
Nephrectomy
1
2014
175
0.100
Why?
Middle Aged
5
2025
28939
0.080
Why?
Combined Modality Therapy
1
2014
1261
0.080
Why?
Treatment Outcome
4
2025
13017
0.080
Why?
Adult
5
2025
31755
0.080
Why?
Young Adult
3
2025
10126
0.070
Why?
Aged
4
2025
21279
0.060
Why?
Indazoles
2
2016
35
0.060
Why?
Male
5
2025
65464
0.060
Why?
Cystoscopy
1
2005
43
0.060
Why?
Urinalysis
1
2005
73
0.050
Why?
Prognosis
1
2014
4965
0.050
Why?
Female
5
2025
71430
0.050
Why?
Humans
6
2025
132158
0.040
Why?
Algorithms
1
2005
1690
0.030
Why?
Aged, 80 and over
2
2016
6924
0.030
Why?
Disease-Free Survival
1
2016
910
0.030
Why?
Neoplasm Metastasis
1
2016
710
0.030
Why?
Survival Analysis
1
2016
1521
0.020
Why?
Drug Therapy, Combination
1
2015
1171
0.020
Why?
Adolescent
1
2025
21018
0.020
Why?
TEEGAVARAPU's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (36)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_